Utah Medical Products, Inc.UTMDNASDAQ
Loading
EBITDA as a percentage of revenue
3Y CAGR
-5.5%/yr
vs -0.1%/yr prior
5Y CAGR
-2.7%/yr
Consistent
Acceleration
-5.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 43.31% | +7.8% |
| 2024 | 40.19% | -18.4% |
| 2023 | 49.28% | -4.1% |
| 2022 | 51.40% | -3.6% |
| 2021 | 53.34% | +7.6% |
| 2020 | 49.59% | -5.1% |
| 2019 | 52.26% | +1.4% |
| 2018 | 51.56% | -2.0% |
| 2017 | 52.60% | +8.7% |
| 2016 | 48.40% | - |